EPAS1 and myocardial infarction: The current studies newly identified a molecular mechanism governing this phenomenon: BMAL1 directly interacts with HIF2A to form a transcriptionally active heterodimer, which drives the circadian variation of myocardial injury in both the acute and long-term phases in mice post-MI.